Navigation Links
GSK and XenoPort Resubmit New Drug Application for Solzira(TM) in Restless Legs Syndrome
Date:1/9/2009

LONDON, RESEARCH TRIANGLE PARK, N.C. and SANTA CLARA, Calif., Jan. 9 /PRNewswire-FirstCall/ -- GlaxoSmithKline and XenoPort, Inc. announced today that GSK has resubmitted the New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) requesting approval of Solzira(TM) (gabapentin enacarbil) Extended Release Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).

The FDA had requested that the data in a single study be reformatted. In addition, GSK conducted a review of other clinical studies taking this input into account. The withdrawal was not related to the content of the filing.

GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit www.gsk.com.

Solzira - is a new chemical entity that is designed to improve upon the pharmacokinetics of gabapentin by taking advantage of high-capacity transport mechanisms in the gastrointestinal tract to improve absorption.

XenoPort - is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilise the body's natural nutrient transport mechanisms to improve the therapeutic benefits of existing drugs. XenoPort is developing its lead product candidate in partnership with Astellas Pharma Inc. and GSK. As announced today, GSK has resubmitted to the FDA an NDA for Solzira for the treatment of moderate-to-severe primary RLS. XenoPort's product candidates are also being studied for the potential treatment of gastroesophageal reflux disease, migraine headaches, neuropathic pain, spasticity related to spinal cord injury, acute back spasms and Parkinson's disease. To lea
'/>"/>

SOURCE GlaxoSmithKline; XenoPort, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. MicroDose and Nexus6 Announce Collaboration to Evaluate Application of Remote Patient Compliance Monitoring Technology with MicroDoses Electronic Dry Powder Inhaler
2. Transcept Pharmaceuticals Announces FDA Acceptance for Review of New Drug Application for Intermezzo(R)
3. OmegaGenesis Announces Angiogenesis Application Collaboration
4. t2cure Acquires Patent Family on In Vitro Potency Testing of Stem Cells for Cardiovascular Application
5. ISTA Pharmaceuticals Files New Drug Application with U.S. FDA for Bepreve(TM)
6. Call for Applications: The Amgen Award for Science Teaching Excellence
7. Savient Submits Biologics License Application (BLA) for pegloticase
8. GenOdyssee Receives Broad Product Applications Protection in EU for Founding Natural Evolution Technology
9. Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Submits New Drug Application to FDA for Carisbamate
10. Penn State gets $5M NSF grant for Nanotech Applications and Career Knowledge
11. FDA Continues Review of Takedas New Drug Application for Alogliptin (SYR-322), a DPP-4 Agent for Type 2 Diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...s services to three out of top five ,global pharma...hester, NY (PRWEB) December 1, 2009 -- iCardiac Te...iac core lab services and QT analysis, announced t...lected iCardiac as a preferred vendor of ECG core ...ted QT(sm) and Dynamic QT beat-to-beat(sm) service...
(Date:12/1/2009)...34-year veteran of the high-technology industry, h... development and intellectual property management ...ce. The company also plans to invest in promising...r. , Monterey, CA (PRWEB)... veteran of the high-technology industry, has form...
(Date:11/30/2009)...ernational team of applied scientists from Harvard...ated compact, multibeam, and multi-wavelength lase...ctrum (infrared). By contrast, typical lasers emit... The innovative multibeam lasers have potential us...ng pollution monitoring, optical wireless, and int...
(Date:11/30/2009)...swire/ -- Acuo Technologies, developers of high-pe...migration tools and services, today announced cont...w Vendor Neutral Archive (VNA), providing the foun...of hospitals, clinics and affiliates. ,, The ar... DICOM Services Grid(TM) Software. The Acuo VNA a...
Breaking Biology Technology:Another Top Five Pharmaceutical Company Selects iCardiac as Preferred Provider of ECG Core Lab Services 2Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 2Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 4Scientists demonstrate multibeam, multi-functional lasers 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 3
...tom Products, Inc., has obtained exclusive distrib...ne, CureCeuticals, invented by, Dr. Marc Selner,...nail Fungus and Cure Athlete,s ... and Founder,of Innovative Custom Products, Inc., ...istribution rights to a "first of its kind" produc...
...., Nov. 7 ARYx Therapeutics,Inc. announced today ...5,000,000 shares of its common stock at a price of... ARYx Therapeutics. In addition, ARYx,Therapeutics...urchase up to,an additional 750,000 shares to cove...n stock will trade on the NASDAQ Global Market und...
... Nov. 7 BioSpace, the leading biotech job,board a... 300 biotechnology,and pharmaceutical job seekers ...Bethesda, MD. The BioSpace Career Fair attracted ...rmaceutical, medical device, and diagnostics caree...y cluster and Mid-Atlantic,region. The event offer...
Other Biology Technology:Medical Breakthrough ... Doctor Discovers 'Penetrating Carrier' That Eradicates Fungus 2ARYx Therapeutics, Inc. Announces Pricing of its Initial Public Offering 2BioSpace Career Fair in Bethesda, Maryland Draws Hundreds of Industry Professionals 2
(Date:12/1/2009)...eo of individual breast tissue cells reveals a nev...ein that cycles between two major compartments in ...lete view of the internal signals that cause breas...cer and are targets of drug development. , The ...actors, travels back and forth between the nucleus...
(Date:12/1/2009)...o the radio anymore. They,re used in everything fr... Carolina State University is revolutionizing the ...ntennas that open the door to a host of new uses i...ployment. , Modern antennas are made from copper... far they can be bent and how often before they ...
(Date:11/30/2009)...d to monitor the commitments that will be made by ...forestation rates, according to research at the Un...s and research groups have failed to make full use...,s surface collected each week to monitor tropical...Grainger in the Proceedings of the National Acade...
Breaking Biology News(10 mins):ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 2ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 3ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 4Shape shifters: Researchers create new breed of antennas 2World forest observatory needed to monitor vital role of forests in climate deal 2Why Watching TV Sports Increases Heart Attacks 61458 1Medical Tests Hit Heart Patients With High Doses of Radiation 61456 1Medical Tests Hit Heart Patients With High Doses of Radiation 61456 2Medical Tests Hit Heart Patients With High Doses of Radiation 61456 3Patriot Risk Services Inc Receives URAC Case Management Accreditation 61454 1Patriot Risk Services Inc Receives URAC Case Management Accreditation 61454 2
...THESDA, Md. (Mar. 18, 2009) ,Adaptation to exercis... not: A sedentary person takes up jogging and can ...ularly for a few weeks, the person can jog a mile,...body adapts, becoming fitter and more efficient. T...en to the muscles. The muscles get stronger, and s...
...SHINGTON (17 March 2009) -- Guruprasad Madhavan is...hat may help prevent osteoporosis, heart failure a... blood pressure. , Madhavan,s research is a majo...009 "New Face of Engineering." , "My energy to p...sibility to better communicate engineering," Madha...
...THLEHEM, PA, March 17, 2009 -- Lehigh University a...has been awarded a $1.8 million grant from the Nat...ute on Deafness and Other Communication Disorders ...hanisms in Binaural Processing." The five-year gra... data he first collected under a grant he received...
Other Biology News:Symposium to look at genetic basis of exercise 2Symposium to look at genetic basis of exercise 3Biomedical engineering student recognized as IEEE's 'New Face of Engineering' 2Lehigh researcher awarded $1.8 million NIH grant 2Lehigh researcher awarded $1.8 million NIH grant 3
Osteocalcin ELISA Kit from Invitrogen
Anti-Human Aminopeptidase P2 / XPNPEP2 Affinity Purified Polyclonal Antibody, Unconjugated from R&D Systems
...i host strains are K-12 derivatives that have muta... glutathione reductase (gor) genes, which greatly .... Studies have shown that expression in Origami(DE...ther host even though overall expression levels we...
Donor Equine Serum from Equitech-Bio
Biology Products: